Hematologic Images, Stock Photos & Pictures

White blood cells of a human. Photomicrograph panorama as seen under the microscope, 1000x zoom

Medical scientist conducting research of blood sample for hematologic diseases. Stock video

Precision Oncology and Targeted Oncology Therapy - Conceptual Illustration. Precision Oncology and Targeted Oncology Therapy - Area of medicine that Uses. Precision Oncology and Targeted Oncology Therapy - Area of medicine that Uses Personalized and Genomic-based Approaches to Diagnose and Treat Cancer

Biogen Biotechnology company logo. Logo of Biogen company on samsung tablet on wooden background. Biogen is an American multinational biotechnology, specializing. Logo of Biogen company on samsung tablet on wooden background. Biogen is an American multinational biotechnology, specializing in the discovery, development, and delivery of therapies for the treatment of neurodegenerative, hematologic, and autoimmune diseases to patients worldwide

The old blood tubes for test on reqest form medical testing. In Laboratory

Donor. ULAN-UDE, RUSSIA - APRIL 7: The City Blood Service makes a promo action for donorship popularization. A young volunteer of the service donates blood. ULAN-UDE, RUSSIA - APRIL 7: The City Blood Service makes a promo action for donorship popularization. A young volunteer of the service donates blood, April 7, 2010, Ulan-Ude, Buryatia, Russia.

Myelodysplastic myeloproliferative neoplasm with neutrophilia. Myelodysplastic myeloproliferative neoplasm with neutrophilia is a myeloid neoplasm with. Myelodysplastic myeloproliferative neoplasm with neutrophilia is a myeloid neoplasm with myelodysplastic and myeloproliferative features characterized by persistent neutrophilia in peripheral blood and neutrophilic left-shift. Previously called atypical chronic myeloid leukemia, is a rare hematologic malignancy with an overall dismal prognosis. Bone marrow, Wright x200.

Biogen Biotechnology company logo. Logo of Biogen company on samsung tablet . Biogen is an American multinational biotechnology, specializing in the discovery. Logo of Biogen company on samsung tablet . Biogen is an American multinational biotechnology, specializing in the discovery, development, and delivery of therapies for the treatment of neurodegenerative, hematologic, and autoimmune diseases to patients worldwide

Bone marrow necrosis. in a Burkitt lymphoma. Bone marrow necrosis.. Extensive bone marrow necrosis is infrequent and is usually associated with hematologic. Bone marrow necrosis.. Extensive bone marrow necrosis is infrequent and is usually associated with hematologic disorders, such as leukemias or lymphomas, solid tumors and sickle cell anemia. Note the replacement of hematopoietic tissue by cellular shadows. Bone marrow, HE x200

Donation center. Row of donors checking blood pressure in hemotransfusion clinic

Store of fresh blood. Refrigerator with fresh blood in blood-bags

Transfusing blood. Two young people donating blood in hemotransfusion center

Hematology samples. Hematologic samples in racks waiting for the blood analyzes

Medical equipment. Row of plasma centrifuges in chemical laboratory

Modern blood transfusion center. Row of young people donating their blood

Center of blood transfusion. Young donors in shoe-covers lying in armchairs and gripping flexors

Acute myeloid leukemia with pseudo-Chediak-Higashi granules. Acute myeloid leukemia with pseudo Chediak-Higashi inclusions, a rare morphologic entity. Pseudo-Ch. Acute myeloid leukemia with pseudo Chediak-Higashi inclusions, a rare morphologic entity. Pseudo-Chédiak-Higashi granules are large inclusions in the cytoplasm of blood cells that mimic those seen in hereditary Chédiak-Higashi syndrome but appear as an acquired feature in hematological diseases .Bone marrow Wright x1000.

Medical staff. Man in uniform and protective eyewear holding sample flask with liquid substance

Celgene Biotechnology company. Logo of Celgene company on samsung tablet . Celgene Corporation is an American biotechnology company that discovers, develops and. Logo of Celgene company on samsung tablet . Celgene Corporation is an American biotechnology company that discovers, develops and commercializes medicines for cancer and inflammatory disorders

Human blood smear under microscope. Light photomicrograph showing red blood cells and neutrophil

Medical specialist. Biochemist in whitecoat, gloves and protective eyeglasses standing by plasma centrifuge

Donor blood registration. Doctor registers new donor blood at hemotransfusion station

Celgene Biotechnology company. Logo of Celgene company on samsung mobile. Celgene Corporation is an American biotechnology company that discovers, develops and. Logo of Celgene company on samsung mobile. Celgene Corporation is an American biotechnology company that discovers, develops and commercializes medicines for cancer and inflammatory disorders

Bone marrow with aplastic anemia. It is a severe hematologic condition that causes a deficiency of all blood cell types red blood cells, white blood cells, and

Pure erythroid leukemia. Pure erythroid leukemia is a rare and aggressive subtype of acute myeloid leukemia with predominant erythroid lineage proliferation. Pure erythroid leukemia is a rare and aggressive subtype of acute myeloid leukemia with predominant erythroid lineage proliferation. Bone marrow. Wright x400

Human blood smear under microscope. Light photomicrograph

White blood cells of a human, photomicrograph panorama as seen u. Nder the microscope, 1000x zoom

Bone marrow with aplastic anemia. It is a severe hematologic condition that causes a deficiency of all blood cell types: red blood cells, white blood cells

Celgene Biotechnology company. Logo of Celgene company on samsung tablet. Celgene Corporation is an American biotechnology company that discovers, develops and. Logo of Celgene company on samsung tablet. Celgene Corporation is an American biotechnology company that discovers, develops and commercializes medicines for cancer and inflammatory disorders

White blood cells of a human, photomicrograph panorama as seen u. Nder the microscope, 400x zoom

A phlebotomist nurse bandages the female patient's arm with a bandage after taking blood from a vein. A young woman performs. A phlebotomist nurse bandages the. A phlebotomist nurse bandages the patient's arm with a bandage after taking blood from a vein. A young women performs laboratory tests during medical examination or is at the time of donation process

Female hand putting red drop sign in cardboard box, blood donation center, help. Stock photo

White blood cells of a human, photomicrograph panorama as seen u. Nder the microscope, 1000x zoom

Blood smear form sepsis. Septicemia can progress to sepsis

Pale skin of Asian man. Sign of anemia. Pallor at eyelid. Closeup view

Pale skin of Asian man. Sign of anemia. Pallor at eyelid. Isolated on white

A nurse taking a blood from a young woman for examination in a modern laboratory or hospital. Young adult girl donor is at the. Time of donation process holding. A nurse taking a blood from a young woman for examination in a modern laboratory or hospital. Young adult girl donor is at the time of donation process holding in hand a red bouncy heart shape ball

Nurse hands using cotton wool swab with alcohol to clean the sick newborn baby`s hand. Image of nurse hands using cotton wool swab with alcohol to clean the sick. Image of nurse hands using cotton wool swab with alcohol to clean the sick newborn baby`s hand skin to kill germs before vaccination

COVID-19 Sterile swab stick on the document for testing people over the world. COVID-19 Document for testing people over the world. Analysis of tested people

Pale skin of Asian woman. Sign of anemia. Pallor at eyelid. Pale skin of Asian elderly woman. Sign of anemia. Pallor at eyelid

Blood donor room. At glass block

Pale skin of Asian man. Sign of anemia. Pallor at eyelid. Closeup view

Pale skin of Asian man. Sign of anemia. Pallor at eyelid. Pale skin of Asian young man. Sign of anemia. Pallor at eyelid

Pale skin of Asian man. Sign of anemia. Pallor at eyelid. Pale skin of Asian young man. Sign of anemia. Pallor at eyelid

3d erythrocyte or red blood cell medicine isolated transparent pgn. realistic picture of hemoglobin for hematology, microbiology. Health human illustration

Almaty / Kazakhstan - 10.07.2019: Laboratory venous blood containers. Topic of medicine: employees of the blood center are engaged in laboratory research. Blood. Topic of medicine: employees of the blood center are engaged in laboratory research. Blood collection from donors

Almaty / Kazakhstan - 10.07.2019: Blood Center specialists conduct tests in the laboratory. Topic of medicine: employees of the blood center are engaged in. Topic of medicine: employees of the blood center are engaged in laboratory research

Berdyansk, Ukraine - March 30, 2019: Biogen website homepage. Biogen logo visible on the phone screen, Illustrative Editorial.

ANKRD26-related thrombocytopenia. Bone marrow. ANKRD26-related thrombocytopenia is a non-syndromic autosomal dominant thrombocytopenia with predisposition to. ANKRD26-related thrombocytopenia is a non-syndromic autosomal dominant thrombocytopenia with predisposition to hematologic neoplasm. It is characterized by dysmegakaryopoiesis and a stable elevation of myeloblasts. Bone marrow, Wright x1000.

ANKRD26-related thrombocytopenia. Bone marrow. ANKRD26-related thrombocytopenia is a non-syndromic autosomal dominant thrombocytopenia with predisposition to. ANKRD26-related thrombocytopenia is a non-syndromic autosomal dominant thrombocytopenia with predisposition to hematologic neoplasm. It is characterized by dysmegakaryopoiesis and a stable elevation of myeloblasts. Bone marrow, Wright x1000.

ANKRD26-related thrombocytopenia. Bone marrow. ANKRD26-related thrombocytopenia is a non-syndromic autosomal dominant thrombocytopenia with predisposition to. ANKRD26-related thrombocytopenia is a non-syndromic autosomal dominant thrombocytopenia with predisposition to hematologic neoplasm. It is characterized by dysmegakaryopoiesis and a stable elevation of myeloblasts. Bone marrow, Wright x1000.

ANKRD26-related thrombocytopenia. Bone marrow. ANKRD26-related thrombocytopenia is a non-syndromic autosomal dominant thrombocytopenia with predisposition to. ANKRD26-related thrombocytopenia is a non-syndromic autosomal dominant thrombocytopenia with predisposition to hematologic neoplasm. It is characterized by dysmegakaryopoiesis and a stable elevation of myeloblasts. Bone marrow, Wright x1000.

ANKRD26-related thrombocytopenia. Bone marrow. ANKRD26-related thrombocytopenia is a non-syndromic autosomal dominant thrombocytopenia with predisposition to. ANKRD26-related thrombocytopenia is a non-syndromic autosomal dominant thrombocytopenia with predisposition to hematologic neoplasm. It is characterized by dysmegakaryopoiesis and a stable elevation of myeloblasts. Bone marrow, Wright x1000.

ANKRD26-related thrombocytopenia. Bone marrow. ANKRD26-related thrombocytopenia is a non-syndromic autosomal dominant thrombocytopenia with predisposition to. ANKRD26-related thrombocytopenia is a non-syndromic autosomal dominant thrombocytopenia with predisposition to hematologic neoplasm. It is characterized by dysmegakaryopoiesis and a stable elevation of myeloblasts. Bone marrow, Wright x1000.

ANKRD26-related thrombocytopenia. Bone marrow. ANKRD26-related thrombocytopenia is a non-syndromic autosomal dominant thrombocytopenia with predisposition to. ANKRD26-related thrombocytopenia is a non-syndromic autosomal dominant thrombocytopenia with predisposition to hematologic neoplasm. It is characterized by dysmegakaryopoiesis and a stable elevation of myeloblasts. Bone marrow, Wright x1000.

ANKRD26-related thrombocytopenia. Bone marrow. ANKRD26-related thrombocytopenia is a non-syndromic autosomal dominant thrombocytopenia with predisposition to. ANKRD26-related thrombocytopenia is a non-syndromic autosomal dominant thrombocytopenia with predisposition to hematologic neoplasm. It is characterized by dysmegakaryopoiesis and a stable elevation of myeloblasts. Bone marrow, Wright x1000.

ANKRD26-related thrombocytopenia. Bone marrow. ANKRD26-related thrombocytopenia is a non-syndromic autosomal dominant thrombocytopenia with predisposition to. ANKRD26-related thrombocytopenia is a non-syndromic autosomal dominant thrombocytopenia with predisposition to hematologic neoplasm. It is characterized by dysmegakaryopoiesis and a stable elevation of myeloblasts. Bone marrow, Wright x1000.

ANKRD26-related thrombocytopenia. Bone marrow. ANKRD26-related thrombocytopenia is a non-syndromic autosomal dominant thrombocytopenia with predisposition to. ANKRD26-related thrombocytopenia is a non-syndromic autosomal dominant thrombocytopenia with predisposition to hematologic neoplasm. It is characterized by dysmegakaryopoiesis and a stable elevation of myeloblasts. Bone marrow, Wright x1000.

ANKRD26-related thrombocytopenia. Bone marrow. ANKRD26-related thrombocytopenia is a non-syndromic autosomal dominant thrombocytopenia with predisposition to. ANKRD26-related thrombocytopenia is a non-syndromic autosomal dominant thrombocytopenia with predisposition to hematologic neoplasm. It is characterized by dysmegakaryopoiesis and a stable elevation of myeloblasts. Bone marrow, Wright x1000.

Myelodysplastic myeloproliferative neoplasm with neutrophilia. Myelodysplastic myeloproliferative neoplasm with neutrophilia is a myeloid neoplasm with. Myelodysplastic myeloproliferative neoplasm with neutrophilia is a myeloid neoplasm with myelodysplastic and myeloproliferative features characterized by persistent neutrophilia in peripheral blood and neutrophilic left-shift. Previously called atypical chronic myeloid leukemia, is a rare hematologic malignancy with an overall dismal prognosis. Bone marrow, HE x200.

Myelodysplastic myeloproliferative neoplasm with neutrophilia. Myelodysplastic myeloproliferative neoplasm with neutrophilia is a myeloid neoplasm with. Myelodysplastic myeloproliferative neoplasm with neutrophilia is a myeloid neoplasm with myelodysplastic and myeloproliferative features characterized by persistent neutrophilia in peripheral blood and neutrophilic left-shift. Previously called atypical chronic myeloid leukemia, is a rare hematologic malignancy with an overall dismal prognosis. Bone marrow, Wright x1000.

Myelodysplastic myeloproliferative neoplasm with neutrophilia. Myelodysplastic myeloproliferative neoplasm with neutrophilia is a myeloid neoplasm with. Myelodysplastic myeloproliferative neoplasm with neutrophilia is a myeloid neoplasm with myelodysplastic and myeloproliferative features characterized by persistent neutrophilia in peripheral blood and neutrophilic left-shift. Previously called atypical chronic myeloid leukemia, is a rare hematologic malignancy with an overall dismal prognosis. Bone marrow, HE x200.

Myelodysplastic myeloproliferative neoplasm with neutrophilia. Myelodysplastic myeloproliferative neoplasm with neutrophilia is a myeloid neoplasm with. Myelodysplastic myeloproliferative neoplasm with neutrophilia is a myeloid neoplasm with myelodysplastic and myeloproliferative features characterized by persistent neutrophilia in peripheral blood and neutrophilic left-shift. Previously called atypical chronic myeloid leukemia, is a rare hematologic malignancy with an overall dismal prognosis. Bone marrow, Wright x1000.

Myelodysplastic myeloproliferative neoplasm with neutrophilia. Myelodysplastic myeloproliferative neoplasm with neutrophilia is a myeloid neoplasm with. Myelodysplastic myeloproliferative neoplasm with neutrophilia is a myeloid neoplasm with myelodysplastic and myeloproliferative features characterized by persistent neutrophilia in peripheral blood and neutrophilic left-shift. Previously called atypical chronic myeloid leukemia, is a rare hematologic malignancy with an overall dismal prognosis. Peripheral blood, Wright x1000.

Myelodysplastic myeloproliferative neoplasm with neutrophilia. Myelodysplastic myeloproliferative neoplasm with neutrophilia is a myeloid neoplasm with. Myelodysplastic myeloproliferative neoplasm with neutrophilia is a myeloid neoplasm with myelodysplastic and myeloproliferative features characterized by persistent neutrophilia in peripheral blood and neutrophilic left-shift. Previously called atypical chronic myeloid leukemia, is a rare hematologic malignancy with an overall dismal prognosis. Peripheral blood, Wright x1000.

Myelodysplastic myeloproliferative neoplasm with neutrophilia. Myelodysplastic myeloproliferative neoplasm with neutrophilia is a myeloid neoplasm with. Myelodysplastic myeloproliferative neoplasm with neutrophilia is a myeloid neoplasm with myelodysplastic and myeloproliferative features characterized by persistent neutrophilia in peripheral blood and neutrophilic left-shift. Previously called atypical chronic myeloid leukemia, is a rare hematologic malignancy with an overall dismal prognosis. Peripheral blood, Wright x1000.

Myelodysplastic myeloproliferative neoplasm with neutrophilia. Myelodysplastic myeloproliferative neoplasm with neutrophilia is a myeloid neoplasm with. Myelodysplastic myeloproliferative neoplasm with neutrophilia is a myeloid neoplasm with myelodysplastic and myeloproliferative features characterized by persistent neutrophilia in peripheral blood and neutrophilic left-shift. Previously called atypical chronic myeloid leukemia, is a rare hematologic malignancy with an overall dismal prognosis. Peripheral blood, Wright x1000.

Myelodysplastic myeloproliferative neoplasm with neutrophilia. Myelodysplastic myeloproliferative neoplasm with neutrophilia is a myeloid neoplasm with. Myelodysplastic myeloproliferative neoplasm with neutrophilia is a myeloid neoplasm with myelodysplastic and myeloproliferative features characterized by persistent neutrophilia in peripheral blood and neutrophilic left-shift. Previously called atypical chronic myeloid leukemia, is a rare hematologic malignancy with an overall dismal prognosis. Peripheral blood, Wright x100.

Bone marrow necrosis. in a Burkitt lymphoma. Bone marrow necrosis.. Extensive bone marrow necrosis is infrequent and is usually associated with hematologic. Bone marrow necrosis.. Extensive bone marrow necrosis is infrequent and is usually associated with hematologic disorders, such as leukemias or lymphomas, solid tumors and sickle cell anemia. Note the replacement of hematopoietic tissue by cellular shadows. Note also remnants of cells in apoptosis. Bone marrow, HE x40.

Hematologic disease study: blood cancer, red cell, malignant transformation, cancerous growth, erythrocyte damage. Marrow failure, systemic issue, immune. Hematologic disease study: blood cancer, red cell, malignant transformation, cancerous growth, erythrocyte damage, marrow failure, systemic issue, immune attack, biological threat

Hematologic disease study: blood cancer, red cell, malignant transformation, cancerous growth, erythrocyte damage. Marrow failure, systemic issue, immune. Hematologic disease study: blood cancer, red cell, malignant transformation, cancerous growth, erythrocyte damage, marrow failure, systemic issue, immune attack, biological threat

Hematologic disease study: blood cancer, red cell, malignant transformation, cancerous growth, erythrocyte damage. Marrow failure, systemic issue, immune. Hematologic disease study: blood cancer, red cell, malignant transformation, cancerous growth, erythrocyte damage, marrow failure, systemic issue, immune attack, biological threat

Hematologic disease study: blood cancer, red cell, malignant transformation, cancerous growth, erythrocyte damage. Marrow failure, systemic issue, immune. Hematologic disease study: blood cancer, red cell, malignant transformation, cancerous growth, erythrocyte damage, marrow failure, systemic issue, immune attack, biological threat

Hematologic disease study: blood cancer, red cell, malignant transformation, cancerous growth, erythrocyte damage. Marrow failure, systemic issue, immune. Hematologic disease study: blood cancer, red cell, malignant transformation, cancerous growth, erythrocyte damage, marrow failure, systemic issue, immune attack, biological threat

Hematologic disease study: blood cancer, red cell, malignant transformation, cancerous growth, erythrocyte damage. Marrow failure, systemic issue, immune. Hematologic disease study: blood cancer, red cell, malignant transformation, cancerous growth, erythrocyte damage, marrow failure, systemic issue, immune attack, biological threat

Hematologic disease study: blood cancer, red cell, malignant transformation, cancerous growth, erythrocyte damage. Marrow failure, systemic issue, immune. Hematologic disease study: blood cancer, red cell, malignant transformation, cancerous growth, erythrocyte damage, marrow failure, systemic issue, immune attack, biological threat

Hematologic disease study: blood cancer, red cell, malignant transformation, cancerous growth, erythrocyte damage. Marrow failure, systemic issue, immune. Hematologic disease study: blood cancer, red cell, malignant transformation, cancerous growth, erythrocyte damage, marrow failure, systemic issue, immune attack, biological threat

Hematologic disease study: blood cancer, red cell, malignant transformation, cancerous growth, erythrocyte damage. Marrow failure, systemic issue, immune. Hematologic disease study: blood cancer, red cell, malignant transformation, cancerous growth, erythrocyte damage, marrow failure, systemic issue, immune attack, biological threat

Hematologic disease study: blood cancer, red cell, malignant transformation, cancerous growth, erythrocyte damage. Marrow failure, systemic issue, immune. Hematologic disease study: blood cancer, red cell, malignant transformation, cancerous growth, erythrocyte damage, marrow failure, systemic issue, immune attack, biological threat

Hematologic disease study: blood cancer, red cell, malignant transformation, cancerous growth, erythrocyte damage. Marrow failure, systemic issue, immune. Hematologic disease study: blood cancer, red cell, malignant transformation, cancerous growth, erythrocyte damage, marrow failure, systemic issue, immune attack, biological threat